Nearly 5 percent of pregnant women are prescribed drugs to treat high blood pressure, including some drugs that aren't considered safe for mothers or their babies, according to new research in the American Heart Association's ...
Sep 10, 2012
0
0
Treatment with an ACE inhibitor for lowering high blood pressure showed a significant mortality reduction in patients with a high prevalence of hypertension, according to a report published in the European Heart Journal, ...
Apr 18, 2012
0
0
Scientists from Queen Mary University of London and Barts Health NHS Trust are trialing an investigational medication for high blood pressure (hypertension) in a clinical study which will give patients an injection of the ...
Apr 27, 2022
0
6
When COVID-19 was first seen in the United States, now more than a year ago, doctors considered it a respiratory ailment. But that didn't last long.
Feb 11, 2021
0
5
Patients who feel low when having a cardiac device implanted are more likely to stop taking their heart medications than those without depression, according to research presented today at ACNAP 2023, a scientific congress ...
Jun 24, 2023
0
3
(HealthDay)—A potential COVID-19 survival benefit is suggested in association with initiation or continuation of an angiotensin-converting enzyme inhibitor (ACE-I), an angiotensin receptor blocker (ARB), or metformin for ...
Jan 10, 2022
0
13
Too much sugar can set people down a pathway to heart failure, according to a study led by researchers at The University of Texas Health Science Center at Houston (UTHealth).
Jun 14, 2013
0
0
According to new research published Online First in the Lancet, body mass index may influence which blood pressure medications work best at reducing the major complications of high blood pressure (strokes, heart attacks, ...
Dec 5, 2012
0
0
Sacubitril-valsartan is reasonably cost effective compared to widely-used therapies for reducing mortality and morbidity in patients with reduced ejection fraction heart failure. The findings are published in Annals of Internal ...
Aug 29, 2016
0
0
Two new practice parameters from the Joint Task Force for Practice Parameters (JTFPP) offer evidence-based recommendations for the diagnosis and management of anaphylaxis and atopic dermatitis (AD) in pediatric and adult ...
Dec 19, 2023
0
0
